Global Nanomedicines Market Size, Status and Forecast 2019-2025

Global Nanomedicines Market Size, Status and Forecast 2019-2025

  • QYResearch
  • January 2019
  • Healthcare
  • 90 pages

Report Description

1
1
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
In 2018, the global Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicines development in United States, Europe and China.

The key players covered in this study
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA

Market segment by Type, the product can be split into
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others

Market segment by Application, split into
Hospitals
Clinics
Research Institute

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nanomedicines status, future forecast, growth opportunity, key market and key players.
To present the Nanomedicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Have query on this report?

Make an Enquiry
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
List of Tables and Figures
Table Nanomedicines Key Market Segments
Table Key Players Nanomedicines Covered
Table Global Nanomedicines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nanomedicines Market Size Market Share by Type 2014-2025
Figure Nanoparticles Figures

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074